[HTML][HTML] Natriuretic peptides and cardio-renal disease

M Volpe - International journal of cardiology, 2014 - Elsevier
The natriuretic peptide (NP) system is an important endocrine, autocrine and paracrine
system, consisting of a family of peptides which provide cardiac, renal and vascular effects …

Promise of SGLT2 inhibitors in heart failure: diabetes and beyond

P Martens, C Mathieu, FH Verbrugge - Current treatment options in …, 2017 - Springer
Opinion statement This review provides mechanistic insight in the pleiotropic effects of
sodium-glucose transporter-2 (SGLT-2) inhibitors with particular interest to the …

Prognostic value of estimated plasma volume in heart failure

K Duarte, JM Monnez, E Albuisson, B Pitt, F Zannad… - JACC: Heart Failure, 2015 - jacc.org
Objectives: The purpose of this study was to assess the prognostic value of the estimation of
plasma volume or of its variation beyond clinical examination in a post-hoc analysis of …

Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes

AS Androne, K Hryniewicz, A Hudaihed… - The American journal of …, 2004 - Elsevier
Clinically unrecognized intravascular volume overload may contribute to worsening
symptoms and disease progression in patients with chronic heart failure (CHF). The present …

Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the …

P Rossignol, JGF Cleland, S Bhandari, S Tala… - Circulation, 2012 - ahajournals.org
Background—We evaluated the effect of the selective mineralocorticoid receptor antagonist
eplerenone on renal function and the interaction between changes in renal function and …

Calculated plasma volume status and prognosis in chronic heart failure

HZ Ling, J Flint, M Damgaard, PK Bonfils… - European journal of …, 2015 - Wiley Online Library
Aims Plasma volume (PV) expansion hallmarks worsening chronic heart failure (CHF) but
no non‐invasive means of quantifying volume status exists. Because weight and …

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trials

P Rossignol, S Masson, S Barlera… - European Journal of …, 2015 - Wiley Online Library
Aims Uncertainties remain on the biological and prognostic significance and therapeutic
implications of loss in body weight (W‐LOSS) in chronic heart failure (HF) patients. We …

Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure

Y Sato, A Yoshihisa, Y Kanno, S Watanabe… - Open …, 2017 - openheart.bmj.com
Objective Liver dysfunction due to heart failure (HF) is known as congestive hepatopathy. It
has recently been reported that liver stiffness assessed by transient elastography reflects …

Chloride in heart failure syndrome: its pathophysiologic role and therapeutic implication

H Kataoka - Cardiology and Therapy, 2021 - Springer
Until recently, most studies of heart failure (HF) focused on body fluid dynamics through
control of the sodium and water balance in the body. Chloride has remained largely ignored …

Measuring impedance in congestive heart failure: current options and clinical applications

WHW Tang, W Tong - American heart journal, 2009 - Elsevier
Measurement of impedance is becoming increasingly available in the clinical setting as a
tool for assessing hemodynamics and volume status in patients with heart failure. The 2 …